Evolutionary Genomics, Inc. FNAM
0.00 USD 0.00 (+0.00%)
At close·Nov 3, 2026, 4:00 PM EST
0.0002 52-week range 0.45
- YTD
- 0.00%
- 1 year
- 0.00%
Altman Z-Score
-14.34 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
1 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
P/E -2.0×
P/S 0.0×
P/B -2.9×
P/FCF -7.0×
EV/EBITDA -8.4×
EV/Sales 0.0×
FCF Yield -14.3%
Gross Margin 0.0%
Operating Margin 0.0%
Net Margin 0.0%
ROE 123.4%
ROIC -92.6%
ROA -82.2%
Revenue 0.0%
Operating Income 30.0%
EPS (diluted) 32.7%
Free Cash Flow 59.5%
Current Ratio 3.9×
Quick Ratio 3.9×
Debt / Equity -2.4×
Net Debt / EBITDA -3.5×
Interest Coverage 0.0×
Dividend Yield 0.0%
Payout Ratio 0.0%
Annual · latest fiscal year ends 2022-12-31